EP PerMed RITC2026: Publication of a transnational call for research, innovation and technology

The Ministry of Health (hereinafter referred to as "MZD") publishes on 1 October 2025, in accordance with Act No. 130/2002 Coll., on support for research, experimental development and innovation from public funds and on amendments to certain related acts (Act on support for research, experimental development and innovation), as amended (hereinafter referred to as "the Act"),

the European Partnership for Personalised Medicine (PerMed) transnational research, innovation and technology call: Test and Demonstration of Multimodal Data Approaches for Personalised Medicine ("MultiPMData2026")

Call 2026

Deadline for announcement of results
September 2026

National budget allocation for the call
250 000 EUR

Maximum amount of support per project
125 000 EUR

Maximum aid intensity per project
Table: Maximum possible aid intensity by type of entity and type of research (according to the current version Methodology: European Partnerships in Health)

Applicants
research organisation, enterprise, patient organisations

Project duration
3years / 36 months

Deadlines for submission of project proposals:
Pre-proposals: 12 Jan 2026, 14:00 CET
Full proposals: 27 Apr 2026, 14:00 CEST

Interested parties are invited to attend the International Information Webinar on October 28, 2025 from 10:00 - 12:00 (CET). Registration is mandatory. The form to complete is available at this link: REGISTRATION

Documents

Terms and conditions for Czech bidder's participation in PerMed Call 2025

Methodology: European Partnerships for Health

Sub-programme 3: European Partnerships in Health - effective from 22.5.2024

Mandatory attachments of the Czech applicant for Phase 1 (pre-proposals)

  1. Affidavit on behalf of the tenderer or co-tenderer (PO)
  2. Affidavit on behalf of the tenderer or co-tenderer (FO)
  3. Affidavit for research organisations (if applicable)
  4. Affidavit of consortium composition (only if a Czech company is represented in the project)
  5. Budget tableAZV ČR Application Form)

Mandatory annexes of the Czech applicant for Phase 2 (full proposals)

  1. Affidavit of competence;
  2. Updated budget table (AZV ČR Application Form)

Other documents

Commission Regulation

Frascati manual

Definition of types of results

Support contract_PerMed Call 2025

The official call documents are available here

Information about the call

This transnational call by the PerMed Partnership (European Partnership for Personalised Medicine): Test and Demonstration of Multimodal Data Approaches for Personalised Medicine ("MultiPMData2026") aims to:

  • linking businesses with clinical stakeholders, including healthcare providers, patients and researchers, to test innovative solutions in controlled real-world settings; these solutions should address specific and clearly defined needs in the care of patients with multiple chronic conditions that require long-term, coordinated care (multimorbidity);
  • Fund innovative projects in the field of human health, focusing on the use of heterogeneous (multimodal) data in personalised medicine approaches, with the aim of more efficient and individualised management of care for patients with two or more chronic diseases requiring continuous healthcare (multimorbidity).

Projects will address at least one of the following aspects: 

  • recognising or describing the presence of other diseases that occur together in patients with chronic diseases;
  • diagnosing or monitoring disease progression, including periods of improvement and relapse;
  • supporting the transition from inpatient to outpatient care through remote monitoring or reporting using wearable devices or other technical tools;
  • decision support for treatment choices (e.g. type and dose of treatment);
  • monitoring and managing multiple treatments (including drug combinations) to increase the effectiveness of treatment or reduce the risk of side effects and harmful drug combinations;
  • ensuring adherence to long-term treatment regimens. 

Project proposals must include a clearly described and high-quality strategy for the collection, processing and use of diverse (multimodal) health data.

Transnational project consortia must include a clinical partner and at least one SME or industrial partner. 

Large-scale clinical trials are not covered by this call and will not be supported under this call. 

Size of the project consortium

Each consortium must include at least 3 partners from 3 different EU Member States or associated countries whose funding organisations are participating in the call. Each of these partners must be eligible and apply for funding from the relevant funding organisation. All 3 legal entities must be independent of each other. A maximum of 3 eligible partners from the same country are allowed per consortium . The project coordinator must be eligible for funding by its regional/national funding organisation participating in the call. The project coordinator may not be changed between the first and second phase. A maximum of 2 self-funding partners are allowed in the consortium , with at least 3 partners eligible for funding from the national funder. The maximum number of partners is 7. Patient organisations may be added as an additional partner by securing their own funding or by applying for EP PerMed funding or by applying for national funding if the conditions of the respective funding organisation allow.

Only transnational projects will be funded.

List of participating countries:

Belgium (FIO (VLAIO)), Belgium (SPW EER), Czech Republic (MZCR/AZVCR), Finland (BFRK), France (ANR), Ireland (HRB), Israel (CSO-MOH, IRDR), Italy (IT-MoH), Latvia (LZP), Lithuania (LMT), Portugal (Centro Region - CCDR), Romania (UEFISCDI), Slovakia (CVTI SR), South Africa (SAMRC), Spain (CSCJA, CFN), Sweden (VINNOVA), Turkey (TUBITAK).

*The list of participating countries is current as of 1 October 2025.

Call rules:

The call is governed by transnational rules common to applicants from all participating countries. In addition to the transnational rules, Czech applicants must also comply with the national conditions set by the relevant national provider. Applicants participating in applied research projects will therefore have to comply with national conditions based on Sub-programme 3: European Partnerships in Health.

Contact person:

Mgr. Monika Kocmanová

+ 420 778 973 186

You can also submit questions about the transnational call via email: .